Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 19, 2025 Amicus Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
Amicus price target lowered to $17 from $18 at Wells Fargo
Wells Fargo analyst Tiago Fauth lowered the firm’s price target on Amicus (FOLD) to $17 from $18 and keeps an Overweight rating on the shares.
Amicus Therapeutics (NASDAQ:FOLD) Lowered to “Hold” Rating by StockNews.com
Amicus Therapeutics (NASDAQ:FOLD – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Thursday. A number of other ...
Amicus files automatic mixed securities shelf
EST Amicus (FOLD) files automatic mixed securities shelfDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...